This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Mahendar Macha: Innovator in the Synthesis of (S)-equol
Introduction
Mahendar Macha, an accomplished inventor based in Medak, India, has made significant contributions to the field of organic synthesis. With a focus on creating innovative methods for chemical processes, he has garnered attention for his work in producing (S)-equol, a compound of growing interest in pharmaceutical applications.
Latest Patents
Mahendar Macha holds one notable patent titled "Process for producing (S)-equol". This patent outlines an improved methodology for the preparation of (S)-equol and includes novel intermediates that facilitate its synthesis. The insights provided in his patent are expected to advance the efficiency of producing this compound, which holds promising therapeutic potential.
Career Highlights
Currently, Mahendar Macha is a part of Dr. Reddy's Laboratories, Incorporated, a leading global pharmaceutical company known for its innovative approaches in drug development. His role in the organization allows him to collaborate with top researchers and contribute to significant advancements in medical science through his expertise in chemical processes.
Collaborations
Throughout his career, Mahendar has worked alongside distinguished colleagues, including Vilas Hareshwar Dahanukar and Syam Kumar Unniaran Kunhimon. These collaborations have enabled him to expand his research capabilities and refine his methods, fostering a stimulating environment for innovation.
Conclusion
Mahendar Macha's dedication to exploring new avenues in chemical synthesis, especially with his work on (S)-equol, exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, backed by his patent and collaborative efforts, are poised to have a lasting impact on the field, inspiring future inventors and researchers alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
